Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation

Abstract

Cervical cancer is the second leading cause of cancer deaths in women worldwide. In recent years, the studies find that inflammation is a critical component of tumor progression, and the ideal therapeutic methods should be aimed at the inflammation reaction triggers. (1β,3β,5β,25S)-spirostan-1,3-diol1-[α-L-rhamnopyranosyl-(1 → 2)-β-D-xylopyranoside] (RCE-4) was the main active composition of Reineckia carnea (Andr.) Kunth. It significantly induced apoptosis in cervical cancer Caski cells through the mitochondrial pathway in our previous studies; however, its underlying mechanism remains poorly understood. This study aimed to further evaluate the effect of RCE-4 on human cervical cancer HeLa cells. Based on this observation, we investigated the anti-cervical cancer effect of RCE-4 by modulating phosphatidylinositol 3-kinase/protein kinase-B/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway, nuclear factor-kappa B (NF-κB) activation, and inflammation-related key factors in HeLa cells. The results indicated that the HeLa cell was the most sensitive with an IC50 of 7.01 μM; RCE-4 significantly promoted the release of cellular lactate dehydrogenase (LDH); increased DNA fragmentation and apoptosis; reduced PI3K, Akt, mTOR, and NF-κBp65 phosphorylation levels; increased the Bax and cleaved poly (ADP-ribose) polymerase (PARP) protein levels; suppressed Bcl-2 protein expression; elevated the Bax/Bcl-2 expression ratio; and decreased the interleukin-1 beta (IL-1β) and interleukin-6 (IL-6) mRNA expressions in HeLa cells in a concentration-dependent manner. These findings suggest that RCE-4 exerted beneficially anti-cervical cancer effect on HeLa cells, mainly inhibiting PI3K/Akt/mTOR signaling pathway phosphorylation and NF-κB activation, promoting HeLa cell apoptosis. Graphical abstract Anti-tumor effect of RCE-4 on HeLa cells.

RETRACTED ARTICLE: Moringa isothiocyanate complexed with α-cyclodextrin: a new perspective in neuroblastoma treatment

“…mTOR controls Akt via a feedback mechanism, which causes the downstream phosphorylation of IκB-α, and the consequent translocation of NF-κB into the nucleus [48, 49]. …”

The role of miR-106p-5p in cervical cancer: from expression to molecular mechanism

“…The results of pathway analyses reveal that all of the three key genes are involved in the pathway of PI3K-Akt signaling pathway, focal adhesion, and Pathways in cancer. With regard to PI3K-Akt signaling pathway, its imbalance in expression is associated with a variety of tumors, including cervical, endometrial, and non-small cell lung cancers 31 – 33 . It is activated during the G1/S transition of the cell cycle and regulates several key cell cycle regulators 34 .…”

Rapamycin Attenuates High Glucose-Induced Inflammation Through Modulation of mTOR/NF-κB Pathways in Macrophages

“…mTOR mediated induction of IKK leads to the activation of NF-κB (Ahmad et al, 2013). NF-κB is an inactive heterodimer composed of p50 and p65 subunits interacting with a member of the inhibitory IκB family in resting cells (Bai et al, 2016). Upon stimulation by activating signals, the IKK complex phosphorylates IκBα, promoting its degradation and freeing NFκB p50/p65 to translocate to the nucleus and initiate transcription (Wang et al, 2017; Morgan et al, 2019).…”